However, the study of Mo has found that using NADPH and PKC inhibitors to down-regulate the expression of TLR2 and TLR4 can improve the continuous inflammation induced by hyperglycemia (Dasu et al., 2008). The gene discussed is TLR4; the disease is Hyperglycemia.